Evolus (EOLS) Debt Ratio (2017 - 2026)
Evolus (EOLS) posted Debt Ratio of 0.71 for Q1 2026, up 9.6% on a QoQ basis from 0.65 in Q4 2025, and up 24.17% year-over-year from 0.57 in Q1 2025.
Evolus (EOLS) Debt Ratio (2017 - 2026) Analysis & Trends
Evolus' Debt Ratio history runs 10 years deep, the most recent figure standing at 0.71 for Q1 2026.
- Quarterly Debt Ratio rose 24.17% year-over-year to 0.71 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.71 (up 24.17% YoY) and the FY2025 annual result came in at 0.65, up 23.8% from the prior year.
- Debt Ratio was 0.71 for Q1 2026 at Evolus, up from 0.65 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.71 in Q1 2026 and bottomed at 0.32 in Q1 2022.
- A 5-year average of 0.53 and a median of 0.53 in 2024 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio jumped 65.44% — and 2024, when it declined 17.96%.
- Evolus' Debt Ratio stood at 0.4 in 2022, then surged by 57.69% to 0.64 in 2023, then declined by 17.96% to 0.52 in 2024, then climbed by 23.8% to 0.65 in 2025, then climbed by 9.6% to 0.71 in 2026.
- Business Quant data shows EOLS's Debt Ratio at 0.71 in Q1 2026, 0.65 in Q4 2025, and 0.67 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.26 |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.42 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.29 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 0.10 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.29 |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.71 |
| Dec 31, 2025 | 0.65 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 0.57 |
| Dec 31, 2024 | 0.52 |
| Sep 30, 2024 | 0.53 |
| Jun 30, 2024 | 0.52 |
| Mar 31, 2024 | 0.53 |
| Dec 31, 2023 | 0.64 |
| Sep 30, 2023 | 0.57 |
| Jun 30, 2023 | 0.56 |
| Mar 31, 2023 | 0.45 |
| Dec 31, 2022 | 0.40 |
| Sep 30, 2022 | 0.37 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.32 |
| Dec 31, 2021 | 0.28 |
| Dec 31, 2020 | 0.36 |
| Sep 30, 2020 | 0.34 |